Massimo Radaelli

Massimo Radaelli is the founder of Cytovia Therapeutics, Inc. Current roles include Executive Chairman & Chief Executive Officer at Bioakos Pharma, Inc. since 2009, Chairman, President & Chief Executive Officer at Noventia Pharma SRL since 2009, Director at Cytovia, Inc., Arriani International SA, Innotex SA, Napo Therapeutics SpA, and Member at Societa Italiana Di Farmacologia.
Since 2024, President-Jaguar International at Jaguar Health, Inc. Former roles include President & Chief Executive Officer at Dompe International SA, Independent Director at ARIAD Pharmaceuticals, Inc. from 2008 to 2016, Independent Director at Stablecoin Development Corp.
from 2014 to 2016, and Director positions at Lavipharm SA, Dompe Farmaceutici SpA, Philogen SpA, Dompé SpA, and Infectious Disease Research Institute.
Education includes an MBA from the University of Bocconi and undergraduate and doctorate degrees from the University of Milan.